WESTHROID Trademark

Trademark Overview

On Tuesday, December 20, 2022, a trademark application was filed for WESTHROID with the United States Patent and Trademark Office. The USPTO has given the WESTHROID trademark a serial number of 97725676. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 18, 2025. This trademark is owned by SPUD Holdings, LLC. The WESTHROID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of thyroid disorders
westhroid

General Information

Serial Number97725676
Word MarkWESTHROID
Filing DateTuesday, December 20, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of thyroid disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSPUD Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAlpharetta, GA 30004
Party NameSPUD Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlpharetta, GA 30004

Trademark Events

Event DateEvent Description
Tuesday, January 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 23, 2022NEW APPLICATION ENTERED
Wednesday, September 20, 2023ASSIGNED TO EXAMINER
Tuesday, October 24, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 24, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 13, 2024SUSPENSION LETTER WRITTEN
Monday, January 22, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, January 22, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, April 11, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 11, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 11, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 13, 2024LETTER OF SUSPENSION E-MAILED
Saturday, April 13, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 2, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 21, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 22, 2025ASSIGNED TO LIE
Tuesday, January 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE

Related Keywords

westhroid disorders thyroid treatment preparations pharmaceutical